| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c106a1d26391c19c91f7686d7291bc40 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
1997-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57e405e25cd8b72b8e6d30aa516da60 |
| publicationDate |
1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5834200-A |
| titleOfInvention |
Marker at the estrogen receptor gene for determination of osteoporosis predisposition |
| abstract |
The present invention relates to a method of determining predisposition to low or high bone mineral density and to development of osteoporosis of a patient, which comprises determining estrogen receptor polymorphism in linkage disequilibrium in a biological sample of said patient, wherein heterozygosity is associated with high bone density and homozygosity is associated with low bone density. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100459493-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006108156-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009104620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009035769-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009035772-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015073707-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008049953-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10172916-B2 |
| priorityDate |
1996-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |